Ypsomed Holding AG
YPSN
Kedudukan dalam Saham
#2948
Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and... Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for safe and simple self-medication companies. The company operates through three segments: Ypsomed Delivery Systems, Ypsomed Diabetes Care, and Others. The Ypsomed Delivery Systems segment provides various injection systems, such as pen injectors, auto-injectors, and wearable injectors, as well as other smart devices. This segment offers its products under the YDS brand. The Ypsomed Diabetes Care segment sells and trades in insulin pumps, infusion sets, pen needles, blood glucose monitoring systems, accessories, and other day-to-day items for diabetics. This segment offers its products under the mylife brand name. The company offers precision turned parts; and contract manufacturing and other services. It markets its products through pharmaceutical partners, as well as through its own distribution network and independent distributors. It operates in Switzerland, Europe, North America, and internationally. Ypsomed Holding AG was founded in 1984 and is headquartered in Burgdorf, Switzerland.
Harga Saham
$469.39
Modal Pasaran
$6.17B
Perubahan (1 hari)
1.63%
Perubahan (1 tahun)
18.98%
Negara
CH
Perdagangan Ypsomed Holding AG (YPSN)
Kategori
Healthcare
Pendapatan untuk Ypsomed Holding AG (YPSN)
Pendapatan pada 2026 TTM: 0
Menurut laporan kewangan terkini Ypsomed Holding AG, pendapatan semasa syarikat ialah 0. Pada tahun 2026, syarikat memperoleh pendapatan sebanyak 0, sama dengan pendapatan pada tahun 2026 yang berjumlah 0. Pendapatan yang dipaparkan di halaman ini adalah pendapatan sebelum faedah dan cukai atau dikenali sebagai EBIT.
Sejarah pendapatan bagi Ypsomed Holding AG dari 2002 hingga 2026
Pendapatan pada akhir setiap tahun
| Tahun | Pendapatan | Ubah |
|---|---|---|
| 2025 | $117.99M | 30.03% |
| 2024 | $90.74M | 46.62% |
| 2023 | $61.89M | 123.73% |
| 2022 | $27.66M | 327.21% |
| 2021 | $6.48M | -20.72% |
| 2020 | $8.17M | -88.37% |
| 2019 | $70.22M | 8.04% |
| 2018 | $64.99M | 17.69% |
| 2017 | $55.22M | 23.00% |
| 2016 | $44.90M | 83.56% |
| 2015 | $24.46M | 41.99% |
| 2014 | $17.23M | 430.74% |
| 2013 | $3.25M | -69.86% |
| 2012 | $10.77M | 28.52% |
| 2011 | $8.38M | -25.03% |
| 2010 | $11.18M | -51.37% |
| 2009 | $22.98M | -23.06% |
| 2008 | $29.87M | 1,042.95% |
| 2007 | $2.61M | -94.71% |
| 2006 | $49.41M | 29.32% |
| 2005 | $38.20M | 235.81% |
| 2004 | $11.38M | 8.53% |
| 2003 | $10.48M | 159.63% |
| 2002 | $4.04M | 0.00% |
Pendapatan untuk syarikat atau pesaing serupa
| Syarikat | Pendapatan | Perbezaan Pendapatan | Negara |
|---|---|---|---|
| $1.09B | - |
IE
|
|
| - | - |
CN
|
|
| - | - |
CH
|
|
| - | - |
CN
|
|
| $74.36M | - |
KR
|
